News & Events
Respiratory technology in the lung: How to bridge fundamental respiratory science with clinical research
Speaker(s): Prof. Daniela Traini, The Woolcock Institute of Medical Research, Sydney, Australia.
When: 15 June 2016 (3:00 - 4:00pm)
Where: SBS Classroom 3 (Level 1)
Type: Seminars

Abstract

This talk gives an overview of the research my group is focused on at the Woolcock Institute of Medical Research. Specifically, it will focus on how to improve drug delivery to the lungs via particle engineering, how repurposing drugs could be used as novel therapeutics for lung diseases and how the development of novel in vitro models enable us to better understand the fate of particles once they deposit in the lung. Basically if you are interested in inhalation pharmaceutical technology come and have a listen. 

Speaker's Bio

Daniela Traini is a Professor in Respiratory Science and an ARC Future Fellow. Prof. Traini's research portfolio covers all areas of respiratory research, from bench to bedside and she is an international leader in pulmonary drug delivery. Prof. Traini leads the Respiratory Technology group (www.respitech.org) at the Woolcock Institute for Medical Research and works in collaboration with Professor Young. Over the last 11 years since joining the University of Sydney, and before during her 5 years in industry, she had developed a leading research program on aerosol drug delivery, from powder engineering, aerosol generation and characterization in vitro to in vivo lung deposition to clinical outcomes. Prof. Traini has extensive experience in both academic and industrial pharmaceutics, and still retains strong link with the pharmaceutical industry. Since 2005 she has published over 155 full peer reviewed manuscripts, has 5 patents and has attracted more than $12 million in competitive funding.